Literature DB >> 15389582

Key role of the achievement of an appropriate ribosomal RNA complement for G1-S phase transition in H4-II-E-C3 rat hepatoma cells.

Massimo Derenzini1, Lorenzo Montanaro, Alessandra Chillà, Elena Tosti, Manuela Vici, Stefania Barbieri, Marzia Govoni, Giuliano Mazzini, Davide Treré.   

Abstract

Cell growth is closely related to cell proliferation and an adequate ribosome biogenesis appears to be necessary for cell duplication. In the present study, we have investigated the relationship between rRNA synthesis and cell cycle progression. For this purpose, in a first set of experiments, we evaluated the effect of rRNA synthesis variation on cycle duration in asynchronously growing H4-II-E-C3 rat hepatoma cells. Cells were either treated with insulin or insulin plus actinomycin D (AMD). The hormone stimulated ribosome biogenesis, which was later followed by an increased synthesis of DNA and a shortening of cell doubling time (DT). Bivariate flow cytometry indicated that the reduced length of the cell cycle was mainly due to the shorter G1-phase. AMD, at the concentration of 0.04 microg/ml, hindered ribosome biogenesis without affecting heterogeneous RNA production. A 12-h reduction in ribosome biogenesis level by AMD caused a lowering of DNA synthesis and a lengthening of cell DT with a longer G1-phase. In a second set of experiments, we analyzed the cell content variations of 28S and 18S rRNA transcripts during G1 phase in H4-II-E-C3 cells, synchronized by serum deprivation, and then stimulated by serum, serum plus insulin, and serum plus insulin and AMD. In control cells, a progressive increase in rRNA content occurred until the highest value of rRNA content was reached 21 h after serum stimulation. In insulin-treated cells, the highest rRNA value was reached at 12 h whereas in AMD-treated cells, the rRNA quantity was constantly low until 18 h and then sharply increased at 21 h. In the three experimental conditions, the highest values of rRNA amount were reached at the end of G1 phase and were quite similar to one another. We also evaluated, by real-time RT-PCR, cyclin E mRNA expression, which appeared to sharply increase at those times in which the maximum increase in the rRNA content was observed. Our results indicated that the achievement of an appropriate amount of rRNA allows G1/S phase transition, probably by modulating the expression of cyclin E mRNA. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15389582     DOI: 10.1002/jcp.20144

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  17 in total

1.  A novel D2O tracer method to quantify RNA turnover as a biomarker of de novo ribosomal biogenesis, in vitro, in animal models, and in human skeletal muscle.

Authors:  M S Brook; D J Wilkinson; W K Mitchell; J L Lund; B E Phillips; N J Szewczyk; H Kainulainen; S Lensu; L G Koch; S L Britton; P L Greenhaff; K Smith; P J Atherton
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-08-15       Impact factor: 4.310

2.  Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate.

Authors:  F Scala; E Brighenti; M Govoni; E Imbrogno; F Fornari; D Treré; L Montanaro; M Derenzini
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

3.  Drosha regulates hMSCs cell cycle progression through a miRNA independent mechanism.

Authors:  Adam Z Oskowitz; Patrice Penfornis; Alan Tucker; Darwin J Prockop; Radhika Pochampally
Journal:  Int J Biochem Cell Biol       Date:  2011-07-20       Impact factor: 5.085

4.  In vitro Assessment of RNA Polymerase I Activity.

Authors:  Marzia Govoni
Journal:  Bio Protoc       Date:  2017-02-05

5.  Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines.

Authors:  L Montanaro; G Mazzini; S Barbieri; M Vici; A Nardi-Pantoli; M Govoni; G Donati; D Treré; M Derenzini
Journal:  Cell Prolif       Date:  2007-08       Impact factor: 6.831

6.  The emerging role of RNA polymerase I transcription machinery in human malignancy: a clinical perspective.

Authors:  Lorenzo Montanaro; Davide Treré; Massimo Derenzini
Journal:  Onco Targets Ther       Date:  2013-07-19       Impact factor: 4.147

Review 7.  MicroRNA-independent roles of the RNase III enzymes Drosha and Dicer.

Authors:  Timothy M Johanson; Andrew M Lew; Mark M W Chong
Journal:  Open Biol       Date:  2013-10-23       Impact factor: 6.411

8.  Nucleolar targeting by platinum: p53-independent apoptosis follows rRNA inhibition, cell-cycle arrest, and DNA compaction.

Authors:  Erica J Peterson; Vijay R Menon; Laura Gatti; Ralph Kipping; Dilhara Dewasinghe; Paola Perego; Lawrence F Povirk; Nicholas P Farrell
Journal:  Mol Pharm       Date:  2014-12-03       Impact factor: 4.939

9.  Synchronization in G0/G1 enhances the mitogenic response of cells overexpressing the human insulin receptor A isoform to insulin.

Authors:  Christine Bonnesen; Gitte-Mai Nelander; Bo Falck Hansen; Pia Jensen; Jonas S Krabbe; Marianne B Jensen; Anne Charlotte Hegelund; Jette E Svendsen; Martin B Oleksiewicz
Journal:  Cell Biol Toxicol       Date:  2009-11-08       Impact factor: 6.691

10.  The nucleolar size is associated to the methylation status of ribosomal DNA in breast carcinomas.

Authors:  Maria Giulia Bacalini; Annalisa Pacilli; Cristina Giuliani; Marianna Penzo; Davide Treré; Chiara Pirazzini; Stefano Salvioli; Claudio Franceschi; Lorenzo Montanaro; Paolo Garagnani
Journal:  BMC Cancer       Date:  2014-05-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.